Capricor Therapeutics, Inc. (CAPR)
7.83
-0.18
(-2.25%)
USD |
NASDAQ |
Oct 09, 16:00
7.80
-0.03
(-0.38%)
After-Hours: 20:00
Capricor Therapeutics Free Cash Flow : -129.78M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -129.78M |
| March 31, 2026 | -113.96M |
| December 31, 2025 | -81.54M |
| September 30, 2025 | -68.38M |
| June 30, 2025 | -56.38M |
| March 31, 2025 | -47.18M |
| December 31, 2024 | -41.53M |
| September 30, 2024 | -38.33M |
| June 30, 2024 | -36.05M |
| March 31, 2024 | -33.33M |
| December 31, 2023 | -27.64M |
| September 30, 2023 | -23.45M |
| June 30, 2023 | -20.80M |
| March 31, 2023 | -18.11M |
| December 31, 2022 | 1.557M |
| September 30, 2022 | 3.685M |
| June 30, 2022 | 6.664M |
| March 31, 2022 | 8.782M |
| December 31, 2021 | -18.01M |
| September 30, 2021 | -16.14M |
| June 30, 2021 | -15.46M |
| March 31, 2021 | -12.75M |
| December 31, 2020 | -10.60M |
| September 30, 2020 | -8.257M |
| June 30, 2020 | -6.779M |
| Date | Value |
|---|---|
| March 31, 2020 | -6.432M |
| December 31, 2019 | -6.822M |
| September 30, 2019 | -8.792M |
| June 30, 2019 | -10.27M |
| March 31, 2019 | -12.18M |
| December 31, 2018 | -14.18M |
| September 30, 2018 | -13.09M |
| June 30, 2018 | -13.17M |
| March 31, 2018 | -13.19M |
| December 31, 2017 | -14.26M |
| September 30, 2017 | -16.28M |
| June 30, 2017 | -17.00M |
| March 31, 2017 | -18.20M |
| December 31, 2016 | -17.75M |
| September 30, 2016 | -16.71M |
| June 30, 2016 | -16.72M |
| March 31, 2016 | -15.15M |
| December 31, 2015 | -13.95M |
| September 30, 2015 | -13.18M |
| June 30, 2015 | -12.22M |
| March 31, 2015 | -11.14M |
| December 31, 2014 | 2.283M |
| September 30, 2014 | 0.6744M |
| June 30, 2014 | 3.488M |
| March 31, 2014 | 5.694M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| ARS Pharmaceuticals, Inc. | -196.60M |
| SELLAS Life Sciences Group, Inc. | -28.42M |
| Sionna Therapeutics, Inc. | -76.21M |
| Alnylam Pharmaceuticals, Inc. | 793.94M |
| Cytokinetics, Inc. | -580.72M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -31.49M |
| Cash from Investing (Quarterly) | -48.76M |
| Cash from Financing (Quarterly) | -4.243M |
| Free Cash Flow Per Share (Quarterly) | -0.6454 |
| Free Cash Flow to Equity (Quarterly) | -107.31M |
| Free Cash Flow to Firm (Quarterly) | -37.39M |
| Free Cash Flow Yield | -31.58% |